Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis by Mancio, J et al.
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
Epicardial adipose tissue volume assessed by
computed tomography and coronary artery
disease: a systematic review andmeta-analysis
Jennifer Mancio1,2*, Diana Azevedo1, Francisca Saraiva1, Ana Isabel Azevedo2,
Gustavo Pires-Morais2, Adelino Leite-Moreira1,3, Ines Falcao-Pires1, Nuno Lunet4,
and Nuno Bettencourt1
1Department of Cardiothoracic Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal; 2Department of Cardiology, Centro Hospitalar de Vila Nova de
Gaia, Vila Nova de Gaia, Portugal; 3Department of Cardiothoracic Surgery, Centro Hospitalar de Sao Joao, Porto, Portugal; and 4Institute of Public Health of Porto, Rua das
Taipas 135, Porto 4050-600, Portugal
Received 6 August 2017; editorial decision 9 November 2017; accepted 23 November 2017
To conduct a systematic review and meta-analysis on the crude and adjusted associations between epicardial adipose tissue (EAT) volume
determined by computed tomography (CT) and coronary artery disease (CAD). MEDLINE, Scopus, and Web of Science databases were
screened for all observational studies assessing the association between EAT volume and CAD. We calculated pooled odds ratio (OR) or
hazard ratio (HR) and 95% confidence intervals (CI) for the association per 10 cm3 variation of EAT by five different definitions of CAD:
obstructive or significant coronary stenosis (luminal narrowing >_50% and >_70%, respectively), presence of coronary artery calcification
(CAC), myocardial ischaemia, and major adverse cardiovascular events (MACE) using DerSimonian and Laird random-effects models.
Seventy studies were identified comprising 41 534 subjects, mainly derived from community-based or hospital-based low-to-intermediate
pretest probability of CAD populations. Participants with any outcome of CAD had a higher mean volume of EAT than those without.
Accordingly, the analysis of crude associations showed that EAT volume was associated with obstructive stenosis, significant stenosis, any
CAC, and MACE. Based on the analysis of adjusted associations, although attenuated, EAT volume remained associated with obstructive
stenosis (OR 1.055, 95% CI 1.033–1.078; I2 = 63.5%), significant stenosis (OR 1.514, 95% CI 1.262–1.815; I2 = 51.8%), myocardial ischaemia
(OR 1.062, 95% CI 1.006–1.122; I2 = 86.9%), and MACE (HR 1.040, 95% CI 1.024–1.056; I2 = 64.7%) but was only borderline significant
with CAC (OR 1.007, 95% CI 1.000–1.011; I2 = 75.8%). In low-to-intermediate cardiovascular risk subjects, EAT volume was independently
associated with coronary artery stenosis, myocardial ischaemia, and MACE.
...................................................................................................................................................................................................
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Introduction
Over the last decade, several studies have reported a significant asso-
ciation between epicardial adipose tissue (EAT) and coronary artery
stenosis,1–36 coronary artery calcification (CAC),18,27,33,37–52 myocar-
dial ischaemia,1,15,19,22,44,53–58 and major adverse cardiovascular
events (MACE).10,45,59–70 However, it remains controversial whether
EAT per se is associated with coronary artery disease (CAD) or
whether these associations result from shared cardiovascular risk
factors.
The EAT is the visceral fat of the heart located between the
visceral pericardium and the myocardium that under physiological
conditions exerts cardioprotective functions, but, in dysmetabolic
states, it has been associated with arterial hypertension, diabetes mel-
litus, dyslipidaemia, and global and visceral obesities.18,34,49,71,72
Despite these strong correlations, some clinical studies showed
that EAT remains independently associated with CAD.50,59,73
However, other studies revealed that this association was no longer
significant after adjustment for established cardiovascular risk
factors.1,12,14
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The interest in EAT relies on not only its key localization and pecu-
liar metabolic properties but also its clinical measurability. EAT vol-
ume can be calculated in the same non-contrasted computed
tomography (CT) scanning of CAC score and, although currently
unclear, EAT volume might complement the prognostic information
provided from the calcium scoring and might increase the predictive
value of non-contrasted cardiac CT without additional radiation
exposure or contrast administration.45,61,65
In this systematic review and meta-analysis, we aimed to compute
the crude and cardiovascular risk factors-adjusted association
between EAT volume, determined by CT, with obstructive stenosis,
significant stenosis, presence of CAC, evidence of myocardial
ischaemia and MACE. As a secondary aim, we performed a subgroup
analysis by obesity, ethnicity and method of EAT volume
quantification.
Methods
Search strategy
This study followed the protocols specified in the Preferred Reporting
Items for Systematic Reviews and Meta-analysis statement.74 A compre-
hensive MEDLINE, Scopus, and Web of Science search of the literature
assessing the association between EAT and CAD was performed. To
identify and retrieve all potentially relevant articles regarding this topic,
the search was performed utilizing the following expression: [(‘epicardial
adipose tissue’ OR ‘epicardial fat’ OR ‘subepicardial adipose tissue’ OR
‘subepicardial fat’ OR ‘cardiac adipose tissue’ OR ‘cardiac fat’) AND (‘cor-
onary artery disease’ OR ‘coronary artery calcification’ OR ‘coronary
artery calcium score’ OR ‘coronary stenosis’ OR ‘coronary athe-
rosclerosis’ OR ‘myocardial ischemia’ OR ‘myocardial perfusion defects’
OR ‘acute coronary syndrome’ OR ‘major adverse cardiovascular even-
ts’)]. An additional manual search was performed by analysing the refer-
ence list of original publications and review articles. The search was
restricted to articles that were published until 23 January 2016.
Eligibility criteria
Only full-size articles of English language published in peer-reviewed jour-
nals were considered for this meta-analysis. Observational cross-
sectional studies, case–control studies, or cohort studies were eligible for
this meta-analysis if the following requirements were met:
(1) Inclusion of adult (>18 years old) participants;
(2) Quantification of EAT volume using cardiac CT;
(3) Description of the crude and adjusted association measures
between the EAT volume and CAD outcomes.
Studies were excluded if they were conducted in special patient popu-
lations: immune-mediated diseases, human immunodeficiency virus infec-
tion, on dialysis chronic kidney disease, diabetic and pregnant women. If
multiple articles were published from the same cohort, we included data
from the study with the most detailed report of and/or the largest sample
size.
Data quality assessment
Potentially relevant articles were evaluated by two independent
reviewers (J.M. and D.A.) using a standardized form and any disagreement
was subsequently resolved by all authors. Methodological quality of all
studies was assessed using the revised and validated version of the
Methodological Index for Non-Randomized Studies (MINORS).75
Statistical analysis
We computed summary measures for the association of EAT with five
different definitions of CAD: (i) presence of obstructive stenosis defined
by the presence of at least one coronary artery stenosis higher than 50%
on the CT or invasive angiography; (ii) presence of significant stenosis
defined by the presence of least one coronary artery stenosis higher than
70% on the CT or invasive angiography; (iii) presence of CAC defined as
Agatston calcium score >0 Hounsfield Units (HU); (iv) myocardial
ischaemia defined by the presence of myocardial perfusion defects on at
least two segments, or coronary fractional flow reserve lower than 80%
in at least one coronary lesion, or by the presence of a coronary artery
stenosis higher than 90%; and (v) MACE including non-fatal myocardial
infarction, unstable angina, unplanned myocardial revascularization,
cardiovascular death, and all-cause death that has been studied as a time-
to-event variable. We recorded the EAT volume mean and its standard
deviation (SD) or the median with 25th and 75th percentiles values for
each subgroup of CAD. Then, the EAT volume mean differences, along
with their 95% confidence intervals (CIs) were calculated. The random-
effect model76,77 was used to compute the effect, per 10 cm3 variation, of
EAT on the outcome measures of CAD. The association measures
included odds ratio (OR) and its respective 95% CI for obstructive steno-
sis, significant stenosis, CAC presence, and myocardial ischaemia and haz-
ard ratio (HR) along with the respective 95% CIs for MACE. In a
secondary analysis, we compared the association of EAT volume with
CAD between studies according to the study populations’ BMI, ethnicity
and by the method of EAT quantification, and a meta-regression analysis
was performed to determine their impact on the adjusted association of
EAT with CAD. Heterogeneity between individual studies estimates was
assessed using the Q statistic and I2 statistic.78 A forest plot was con-
structed showing the individual studies with the pooled estimates.
Publication bias was assessed using the Egger test and the funnel plot anal-
ysis, and the trim-and-fill method of Duval and Tweedie.77,79 All statistical
analyses were performed using STATA software (version 13.1,
StataCorp LP, College Station, TX, USA).
Results
Characteristics of the included studies
From a total of 1283 studies initially identified, 77 matched our eligibil-
ity criteria, and 4 additional studies were included after checking the
reference list of the articles. Eleven studies were then excluded
because: (i) represented reports based on the same original study
database (n= 2),80,81 (ii) included only diabetic patients (n= 1),49 or
(iii) comprised insufficient or incongruent data (n= 8).82–90 This
yielded a total of 70 studies included in qualitative analysis and 33 of
those included in quantitative analysis (meta-analysis) (Figure 1). These
studies were assessed as high-quality publications (median MINORS
score of 18; 25th and 75th percentile of 16 and 19, respectively).
Accordingly, this systematic review and meta-analysis comprised
data from 41 534 subjects, mainly derived from community-based or
hospital-based low-to intermediate-pretest probability of CAD
populations. The association of EAT volume with the presence of
coronary stenosis was reported in 36 cross-sectional studies (see
Supplementary data online, Table S1).1–36 The cross-sectional
association of EAT volume with CAC was provided by 18 stud-
ies,1,18,27,33,37–42,45–47,51,52,90 and 4 cohort studies provided data on
the longitudinal association between EAT volume and CAC pro-
gression.43,44,48,50 (see Supplementary data online, Table S2). Ten
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cross-sectional studies reported the association with
myocardial ischaemia (see Supplementary data online, Table
S3).1,15,19,22,53–58 Fourteen cohort studies investigated the link
between EAT and MACE (see Supplementary data online, Table
S4).10,45,59–70 Nine studies provided detailed data addressing the asso-
ciation of EAT volume with specific plaque components (calcified vs.
non-calcified vs. mixed5,13,14,16,23,31 or fibrous vs. lipid vs.
fibrocalcific91) and with plaque eccentricity.36 In two separate studies,
Nakanishi et al.44,70 determined the longitudinal association of changes
in EAT volume with CAC progression and MACE incidence.
Crude association between EAT volume
and CAD
The volume of EAT was significantly higher in subjects who presented
with coronary stenosis, coronary calcification, and myocardial
ischaemia or who suffered MACE in comparison with those without
any evidence of CAD (Figure 2). Based on the analysis of studies pro-
viding the unadjusted association, we found that EAT volume was
strongly associated with obstructive CAD, significant CAD, CAC
presence, and MACE (Figure 3).
Adjusted association between EAT
volume and CAD
Forty-four studies comprising a total of 36 429 participants
reported the association of EAT volume with CAD after adjustment
for measures of obesity, including BMI,1,9,10,12-14,17,18,22,23,27,29,32,
33,36,38,42-46,50,52,62-65,68 waist circumference23,36,51,67 or visceral
abdominal fat,14,18,26,37,42,46,52 and traditional cardiovascular risk
factors1,3,6,9,10,12,14–18,22,27,29,31–33,36,37,42,44,45,51–55,57,61,62,66,68,69,90, with
some studies additionally for the effect of conventional cardiovascular
drugs26,27,46,50,51,68; few studies normalized the EAT volume for body
size2,30,39,43,66 and other included markers of systemic inflamma-
tion29,36,52,62,68 in their models (see Supplementary data online, Table
S5). Figure 4 illustrates the forest plot of studies addressing the adjusted
association of EAT volume with CAD. The analysis of data provided
from the most complete multivariable model showed that, although
attenuated, EAT volume remained associated with the presence of
obstructive and significant stenosis, myocardial ischaemia and MACE
but was only borderline significant for the presence of CAC. Due to
different statistical methods, two studies45,69 addressing the association
between the EAT volume and MACE, namely the large Heinz Nixdorf
Recall cohort study, could not be included in the computation of sum-
mary estimate measure. Both of these studies showed a significant
association between EAT volume and MACE beyond the cardiovascu-
lar risk factors and, therefore, their absence would not affect the direc-
tion of the association of EAT with MACE, and its magnitude above
the unit can, possibly, be higher than that reported in this meta-
analysis.
Secondary analyses
A subgroup analysis of studies focusing on non-obese populations
showed a stronger independent association between EAT volume
and CAD with a pooled association measure of 1.155 (95% CI
1.086–1.228; I2 = 68.5%) vs. 1.012 (95% CI 1.010–1.023) in the
other studies (see Supplementary data online, Figure S1).6,9,23,63
Similarly, the independent association of EAT with CAD was
significantly higher among the Asian studies compared with non-
Asian studies (adjusted estimate of 1.084, 95% CI 1.061–1.108;
I2 = 50.4%).6,9,14,23,29,38,63,64 (see Supplementary data online, Figure S2).
The EAT volume mean differences between subjects with and
Figure 1 Study flowchart.
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..without CAD did not differ according to the image data set (non-con-
trast vs. contrast CT) used to quantify EAT volume (see
Supplementary data online, Figure S3). Supplementary data online,
Table S6 shows the meta-regression coefficients for the effect of study
populations’ BMI and ethnicity and the method of EAT quantification
on the association of EAT with CAD.
Heterogeneity and publication bias
There were significant differences in EAT volume mean values
between individual studies indicated by the statistical test for hetero-
geneity (Q¼ 79.8, I2 = 78.7%, P< 0.001). Similarly, we found signifi-
cant differences in the unadjusted effect and adjusted effect of EAT
on CAD between individual studies (for crude analysis, Q¼ 99.4,
I2 = 72.9%, P< 0.001, and for adjusted analysis, Q= 139.8, I2 = 80%,
P< 0.001). Figure 5 illustrates the asymmetry of funnel plots of publi-
cations that reported the crude (Figure 5A) and adjusted (Figure 5B)
associations of EAT volume with CAD (P-value for crude analysis of
0.031 and for adjusted analysis of <0.001 from Egger test for funnel
plot symmetry). Corresponding to the Duval and Tweedie’s trim-
and-fill input method and after correction for potential unpublished
studies, there was no evidence that publication bias would affect the
adjusted association of EAT with the presence of coronary stenosis
(estimated pooled OR 1.068, 95% CI 1.011–1.128; P= 0.018), CAC
(estimated pooled OR 1.021, 95% CI 0.976–1.069; P= 0.363), MACE
(estimated pooled HR 1.030, 95% CI 1.011–1.063; P = 0.023), or
myocardial ischaemia (estimated pooled OR 1.009, 95% CI 1.001–
1.169; P= 0.042).
Discussion
Main findings
The present systematic review and meta-analysis on the association of
EAT volume determined by CT and CAD was based on 70 published
Figure 2 EAT volume mean differences between subjects with and without CAD by outcome subgroups. EAT volume is given in cubic centimetre.
CAC, coronary artery calcification; CAD, coronary artery disease; EAT, epicardial adipose tissue; MACE, major adverse cardiovascular events.
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studies comprising 41 534 subjects. To improve the validity and useful-
ness of our conclusions, we performed a stratified analysis according to
five different definitions of CAD: obstructive and significant stenosis,
CAC, myocardial ischaemia and MACE. Our results demonstrated that
(i) the volume of EAT was higher in subjects who presented with coro-
nary stenosis, CAC, myocardial ischaemia, and MACE; (ii) in adjusted
analysis these associations remained significant for the presence of
obstructive and significant stenosis, myocardial ischaemia, and MACE
but not for the presence of coronary calcification.
Causes of heterogeneity
In spite of our analysis by subgroups of CAD, significant heterogene-
ity remained between studies (I2 often higher than 75%). Therefore,
other sources of heterogeneity had to be considered.
Study population
The association between EAT and CAD may depend on study popu-
lations’ clinical features such as their pretest probability of CAD
Figure 3 Forest plot of studies describing the crude association of EAT volume with CAD by outcome subgroups. RR* relates to 10 cm3 of EAT
volume. RR* describes the measure of association including the odds ratio with >_1 coronary stenosis >_50%, CAC >0, and myocardial ischaemia and
the hazard ratio with MACE. CAC, coronary artery calcification; CAD, coronary artery disease; EAT, epicardial adipose tissue; MACE, major adverse
cardiovascular events.
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..(community-based vs. hospital-based study populations or sympto-
matic low-to-intermediate vs. high-risk patients), body fat distribution,
ethnicity, or gender. Five community-based prospective cohorts con-
tributed to the pooled results accounting for approximately 20 000
subjects: Framingham Heart Study,46,67 MESA (Multi-Ethnic Study of
Atherosclerosis),36,39,47,52,68 Heinz Nixdorf Recall Study,45,50,68
EISNER (Early Identification of Subclinical Atherosclerosis by Non-
invasive Imaging Research) Study,41,44,53,55,57,69 and Rotterdam
Study.51 This could bias lower the association between EAT and
CAC, given the low prevalence of CAC (e.g. CAC >0) expected in
these very low-risk subjects. Additionally, as a consequence of CT
high sensitivity and negative predictive value for CAD detection, most
of the participants recruited from hospital registries had low-to-
intermediate cardiovascular risk and were referred to CT for exclu-
sion of the disease; few studies included both low-to-intermediate
(the majority) and high-risk or with previously known
CAD1,4,6,8,14,22,32,61 patients and only two studies were conducted in
the setting of acute coronary syndrome.64,66 As we did not have
Figure 4 Forest plot of publications describing the adjusted association of EAT volume with CAD by outcome subgroups. RR* relates to 10 cm3
of EAT volume. RR* describes the measure of association including the odds ratio with >_1 coronary stenosis >_50%, CAC >0, and myocardial ischae-
mia and the hazard ratio with MACE. CAC, coronary artery calcification; CAD, coronary artery disease; EAT, epicardial adipose tissue; MACE, major
adverse cardiovascular events.
6 J. Mancio et al.
Downloaded from https://academic.oup.com/ehjcimaging/advance-article-abstract/doi/10.1093/ehjci/jex314/4718131
by Universidade do Porto user
on 03 April 2018
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..access to individual patient data from all studies reviewed and we
based on published information only, we were not able to model the
impact of patients’ cardiovascular risk on the association of EAT with
CAD, and consequently, our conclusions might not be able to be
extrapolated to high pretest probability of CAD populations.
Body fat distribution differences might also have contributed to
the overall heterogeneity in the sense that some studies suggest a
statistically significant interaction between EAT and BMI.18,29,59,63
Consistently, our subgroup analysis evidenced a stronger association
of EAT with CAD in non-obese patients.
Furthermore, even though Tanami et al.1 and McClain et al.39 did
not find differences in the association of EAT and CAC score across
race/ethnic groups, we showed a higher association between EAT
and CAD in Asian subjects (n= 4990 subjects) compared with the
non-Asians. Fat distribution, in general, and EAT, in specific, varies
among the ethnic group with Blacks having a lower average of EAT
than Whites and Asians1,39 and Asians, generally, having a higher per-
centage of body fat than White people of the same age and gender.92
It remains uncertain but there is evidence suggesting that EAT may
have a different role in the pathophysiology of CAD according to
gender. Some studies showed that EAT was highly associated with
CAC in men than in women.18,36,51 By contrast, McClain et al.39 in
the MESA study, as well as Rosito et al.46 in the Framingham Heart
Study found no sex interaction in the association of EAT with CAC.
Method of EAT volume quantification
Another aspect contributing to heterogeneity might be related to the
methodology applied to measure the EAT volume. We found differ-
ences regarding the attenuation thresholds for fat detection (the
most commonly used was -190 to -30 HU, but the lower limit ranged
from -600 to -190 HU and the upper limit ranged from -50 to
-20 HU), the CT protocol (non-contrast vs. contrasted-CT imaging),
and the CT scanner features. The volumetric assessment of EAT in
CT was initially validated for non-contrast calcium scoring, but the
more recent articless have used contrast CT scans. In this systematic
review and meta-analysis, the EAT volume was quantified using
contrasted-CT in 22 studies.6–10,13,17,22,23,25,26,29,30,32,33,38,70 A recent
paired comparison of the volume of EAT measured in non-contrast
and contrast CT showed that calcium score scanning and coronary
angiography CT image data sets are both feasible for EAT assessment
but its volume can be underestimated in contrast CT acquisition
even after post-contrast attenuation adjustment.93 However, in this
review, the EAT volumes mean differences between subjects with
and without disease did not differ according to the images set used
both in subgroup and in meta-regression analyses.
Statistical methods
Finally, heterogeneity may also result from differences in the statisti-
cal methods. A great variety of strategies and models were found;
here, we presented the results per variation of 10 cm3 of EAT to help
direct comparisons among studies; the variables for which each study
adjusted the association between EAT and CAD can be found in
Supplementary data online, Table S5.
EAT volume was independently
associated with coronary stenosis,
MACE, and myocardial ischaemia but not
with coronary calcification
The results of this systematic review and meta-analysis on low-to-
intermediate cardiovascular risk subjects suggest that EAT is linked to
coronary stenosis, coronary events and myocardial ischaemia, irre-
spective of its association with cardiovascular risk factors. Therefore,
the association of EAT with CAD is not totally explained by shared
cardiovascular risk factors, but EAT, itself, may contribute to limiting-
flow plaque growth, plaque instability, and coronary events. These
findings are supported by two case-control studies including diabetic
and non-diabetic patients who showed a significant association of
EAT with the presence of any coronary plaque in both diabetic
and non-diabetic patients.12,27 Additionally, in a large cohort of
non-obese without metabolic syndrome subjects, Narumi et al.,6
clearly demonstrated that EAT was associated with the presence of
Figure 5 Funnel plot of studies reporting crude (A) and adjusted (B) associations of EAT volume with CAD. RR* describes the measure of associa-
tion including the odds ratio with >_1 coronary stenosis >_50%, CAC >0, and myocardial ischaemia and the hazard ratio with MACE.
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..obstructive stenosis even after controlling for age, sex, and systolic
blood pressure. In contrast, even though EAT volume and CAC
were correlated in univariate analysis, this association depended on
the atherosclerotic risk factors. As previously discussed, this associa-
tion can, possibly, be underestimated considering the prevalence of
CAC in this review population. Nevertheless, in the CORE320 multi-
centre study, which included 67% of intermediate-high and 31% of
high pretest probability of CAD participants, EAT was associated
with CAC in the crude analysis, but it did not hold significant after
controlling for cardiovascular risk factors as well.1 These findings,
together with the reported independent association of EAT with cor-
onary stenosis and coronary events, indicate that EAT may be linked
with coronary atherosclerosis by different signalling pathways from
that of CAC such as the development of non-calcified,16,29,33 and
potentially unstable13,31,91 coronary plaques in low-to-intermediate
risk subjects. Alexopoulos et al.33 showed that EAT volume was
significantly higher in patients with mixed or non-calcified plaques
compared with patients with calcified plaques or with no plaques.
Similarly, Tsushima et al.29 demonstrated, in a cohort of 352 subjects
with CAC score of zero (very low cardiovascular risk) that patients
with higher EAT volume were associated with non-calcified plaques
independently of visceral abdominal fat and cardiovascular risk fac-
tors. These associations were anatomically clarified in the study of Ito
et al.91 who demonstrated, by optimal coherence tomography, that
EAT volume was associated with low-attenuation plaques and exten-
sion of the necrotic lipid pool, correlated inversely with fibrous cap
thickness and predicted independently acute coronary syndromes.
Clinical implications
Irrespective of the potential causal mechanistic pathways that under-
lie the above mentioned associations, our findings might indicate that
EAT and CAC can be both imaging biomarkers of CAD, and conse-
quently, they are associated with each other in crude analysis but
probably refer to different and complementary aspects of the disease.
In the Heinz Nixdorf Recall Study, EAT volume predicted the inci-
dence of MACE even when the CAC score was considered in the
model,45 indicating that EAT can, possibly, add a statistically significant
different and complementary information of that given by CAC
score. Although these data are supported by Groves et al.27 and
Kunita et al.,63 Possner et al.61 found no improved risk stratification
by EAT volume when the CAC score or myocardial perfusion were
known. In contrast, the only study investigating subgroups with the
largest relative advantage of EAT above the CAC score showed that
EAT volume was able to complete the prognostic value of CAC
score but only in patients with marked coronary calcification (CAC
score > 400).65 Furthermore, beyond its diagnostic interest, EAT
measurement may also help as an imaging biomarker of disease pro-
gression and response to treatment. In contrary to CAC score, which
represents an irreversible pathological process, EAT seems to be a
dynamic fat depot that may be affected by lifestyle modifications and
therapies. A significant reduction in the EAT accumulation was shown
after very low-calorie diet,94 bariatric surgery,95 aerobic exercise,96
and statins therapy.97 However, limited studies have explored the
longitudinal association of changes in EAT volume with the incidence
or progression of CAD over time.44,70
Conclusions
The present systematic review and meta-analysis indicates that EAT
is an independent predictor of non-calcified flow-limiting or vulner-
able plaques in low-to-intermediate-risk patients. Further investiga-
tion is required to study whether and in what degree the EAT is
associated with each plaques’ components and high-risk plaque
features and, importantly, to confirm its incremental predictive value
as an adjunct of CAC score or coronary angiography. How to EAT
quantity and quality are related to CAD in high-risk patients have not
been specifically addressed.
Supplementary data
Supplementary data are available at European Heart Journal—
Cardiovascular Imaging online.
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